$2.5 Million Dollar Risperdal Verdict Upheld

Dec 28, 2018
By Boesen Law
  • A Pennsylvania Superior Appeals Court has ruled against overturning a $2.5 million dollar verdict that was awarded to an Alabama man and his family.  The lawsuit is against Johnson & Johnson’s subsidiary company, Janssen Pharmaceuticals. Janssen Pharmaceuticals is the pharmaceutical company behind the antipsychotic medication Risperdal.

    What was the basis for the lawsuit?

    The lawsuit was based on the claim that a young man named Austin Pledger took Risperdal as a teen to treat his autism disorder. As a result of taking Risperdal, he developed Gynecomastia (a condition where breast tissue develops in males). More details about the lawsuit can be found here.

    Why is this significant?

    This lawsuit was considered to be a guinea pig case of sorts, in that it was the first Risperdal lawsuit to reach a verdict that was awarded to the family. This can potentially affect thousands of other lawsuits that are being brought against Janssen Pharmaceuticals under the same claim.

    What happens next?

    The Pledger family has filed an appeal asking for a new trial for punitive damages. Other lawsuits regarding Risperdal have had their verdicts overturned stating a conflict of law issues. Janssen Pharmaceuticals is also considering a second appeal.

    What are my options if I have been affected or know someone who has developed Gynecomastia as a result of using Risperdal?

    If you or a loved one have developed gynecomastia as a result of using Risperdal, contact our office at  to schedule a free consultation and speak with one of our highly experienced attorneys. Please also visit our practice area page on pharmaceuticals at our website here for additional information.